Nuvasive, Inc. v. Absolute Medical, LLC

71 F.4th 861
Court of Appeals for the Eleventh Circuit·Decided June 21, 2023·No. 22-10214·Published·Cited by 5 cases

Opinion

[PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

No. 22-10214

NUVASIVE, INC., Plaintiff-Counter Defendant-Appellee, versus ABSOLUTE MEDICAL, LLC, GREG SOUFLERIS, DAVE HAWLEY, ABSOLUTE MEDICAL SYSTEMS, LLC, RYAN MILLER,

Defendants-Appellants,

USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 2 of 36

2 Opinion of the Court 22-10214

Appeal from the United States District Court for the Middle District of Florida D.C. Docket No. 6:17-cv-02206-CEM-GJK

Before WILSON and JILL PRYOR, Circuit Judges, and RUIZ,* District Judge. JILL PRYOR, Circuit Judge:

NuVasive, Inc. manufactures medical products and equipment to treat spinal disease. In central Florida, NuVasive sold its products through an exclusive distribution agreement with Absolute Medical, LLC, a company owned by Greg Soufleris. Under the agreement, Absolute Medical employed independent-contractor sales representatives who marketed and sold NuVasive’s products to doctors and medical practices in the region. Long before the end of the agreement’s term, Soufleris informed NuVasive that he was dissolving Absolute Medical and ending its business relationship with NuVasive. He started a new company, Absolute Medical Systems , LLC (“AMS”), which began selling products for one of NuVasive ’s competitors.

NuVasive sued Absolute Medical, Soufleris, AMS, and two of Absolute Medical’s sales representatives who began working for AMS, Dave Hawley and Ryan Miller, for breaching the exclusive

* Honorable Rodolfo A. Ruiz II, United States District Judge for the Southern District of Florida, sitting by designation.

USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 3 of 36

22-10214 Opinion of the Court 3

distribution agreement and the included noncompetition agreements . After two years of litigation, the district court enforced a dispute resolution clause in the agreement, ordering NuVasive and Absolute Medical to arbitrate NuVasive’s breach-of-contract claim seeking money damages. The district court stayed most of the other claims during the arbitration. The arbitration panel’s final award found Absolute Medical liable for breaching the agreement but denied NuVasive’s claims for lost profits damages.

Following arbitration, the litigation resumed to resolve NuVasive’s remaining claims.1 In discovery, Absolute Medical produced text messages that Soufleris had sent to Hawley while Hawley testified before the arbitration panel. The text messages concerned the subject matter of Hawley’s testimony, and his testimony on cross-examination appeared to be consistent with answers suggested in Soufleris’s contemporaneous texts. Based on this new information, NuVasive moved the district court to vacate the arbitration panel’s award under 9 U.S.C. § 10(a)(1) on the ground that the award had been procured by fraud. Absolute Medical objected that NuVasive filed the motion to vacate after the

1 While the arbitration was pending, NuVasive moved for summary judgment on its breach-of-contract claim against Absolute Medical that sought injunctive relief (Count I), the breach-of-contract claim against AMS (Count III), and the breach-of-contract claim against Hawley and Miller (Count IV). Hawley, Miller, and AMS moved for summary judgment on the breach-of-contract claim against Hawley and Miller and the conversion claim against Hawley and AMS (Count V).

4 Opinion of the Court 22-10214

statutory three-month deadline, but the district court tolled the deadline and ultimately vacated the arbitration panel’s award.

Absolute Medical, Soufleris, AMS, and the sales representatives now appeal the district court’s order granting NuVasive’s motion to vacate the arbitration panel’s final award. After careful review , and with the benefit of oral argument, we affirm.

I. BACKGROUND

A. NuVasive and Absolute Medical’s Business Relationship

NuVasive is a medical device manufacturer that designs, develops , and markets products for the surgical treatment of spinal disorders. Absolute Medical, owned by Soufleris, employed independent contractors to act as sales representatives to market and sell NuVasive’s products to hospitals and doctors.

Around 2005, Absolute Medical began working with NuVasive to market and sell NuVasive’s products in central Florida. By 2013, NuVasive and Absolute Medical had entered into an exclusive distribution arrangement in which Absolute Medical and its sales representatives would be the sole marketers, distributors, and sellers of NuVasive’s products in a defined territory in Florida that included specific counties as well as certain hospitals in other counties .

This appeal concerns the contract NuVasive and Absolute Medical inked in 2017, when they agreed to extend their exclusive distribution relationship “after many months of negotiation[].”

USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 5 of 36

22-10214 Opinion of the Court 5

Doc. 1 at 4. 2 This contract, entitled “Exclusive Sales Representative Agreement” (the “Agreement”), had a term of five years beginning on January 1, 2017. Like the earlier agreement, it appointed Absolute Medical and its sales representatives as the exclusive sellers of NuVasive’s products in the defined territory. In section 5.09(c) of the Agreement, Absolute Medical promised that during the Agreement ’s five-year term and for one year afterward, Absolute Medical ’s sales representatives would not “represent, promote, sell, solicit , or otherwise commercialize . . . any products or services that [we]re, in NuVasive’s reasonable judgment, competitive with any of NuVasive’s products or services.” Doc. 260-3 at 137. Absolute Medical further agreed that, during the same period, its sales representatives would not “solicit, encourage, or induce, or cause to be solicited, encouraged or induced” any current, former, or prospective NuVasive customers “to terminate or adversely modify any business relationship with NuVasive.” Id. In exchange, NuVasive agreed to provide Absolute Medical’s sales representatives with “extraordinary, specialized, comprehensive, and industryleading training” on NuVasive’s products, which would give the sales representatives “a deep understanding of NuVasive’s products , methodology, trade secrets, and other valuable confidential or proprietary information.” Doc. 188 ¶ 30.

To effect section 5.09(c)’s non-competition and non-solicitation provisions, section 5.09(e) of the Agreement required Absolute

2 “Doc.” refers to the docket entries in No. 6:17-cv-02206 (M.D. Fla.).

6 Opinion of the Court 22-10214

Medical to cause each of its “Representative Affiliate[s]”—in Absolute Medical’s case, its sales representatives—to sign compliance agreements. The compliance agreements incorporated section 5.09(c) of the Agreement. To comply with section 5.09(e), Absolute Medical agreed to have its sales representatives, including Hawley and Miller, sign compliance agreements.

Less than one year into the Agreement’s five-year term, Soufleris informed NuVasive by email of his “resignation” from the Agreement because “[his] time [had] come to move on.” Doc. 188- 4. Just three days later, Soufleris formed AMS. After a week, the Absolute Medical sales representatives who sold NuVasive products resigned. According to NuVasive, the sales representatives then began working for AMS soliciting business from, and performing services for, the same customers they serviced for NuVasive, but on behalf of a different manufacturer, Alphatec, which produced competing products. NuVasive believed that with this conduct , Absolute Medical was violating the Agreement by not enforcing the compliance agreements that it was supposed to have had the representatives sign, and that the sales representatives were violating the compliance agreements by working for Alphatec through AMS.

USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 7 of 36

22-10214 Opinion of the Court 7

Free access — add to your briefcase to read the full text and ask questions with AI

Nuvasive, Inc. v. Absolute Medical, LLC, 71 F.4th 861 (11th Cir. 2023).

71 F.4th 861 (Nuvasive, Inc. v. Absolute Medical, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related